Pantarhei Bioscience BV

Pantarhei Bioscience BV (PRB) is a Dutch limited liability company that specializes in developing innovative treatments for women's health and hormone-related cancers. PRB has established a subsidiary, Pantarhei Oncology (PRO), to focus on Endocrine Cancer treatments. The company's product pipeline is based on identifying novel medical uses of existing molecules, drugs, hormones, biologicals, and combinations thereof. Their areas of expertise include reproductive hormone-related treatments and diseases such as contraception and menopausal hormone therapy (MHT), as well as breast cancer, prostate cancer, and ovarian cancer. PRB develops patent-protected new treatment concepts up to proof-of-concept (PoC) in humans (phase II) and outsources all research and development activities. After successful PoC, data and intellectual property (IP) are licensed out to a licensee or partner for completion of clinical development (phase III), regulatory approval, and sales and marketing.